The neuregulins are a diverse family of proteins that play an important role in controlling the growth and differentiation of glial, epithelial and muscle cells. This review describes recent findings of novel neuregulins (NRG2 and NRG3) and summarizes the tissue distribution and receptor interaction of these ligands.
Several years ago, factors that could regulate Schwann cell proliferation, induce synthesis of acetylcholine receptors or promote phosphorylation of the receptor tyrosine kinase ErbB2 were isolated in different laboratories and designated glial growth factor (GGF), acetylcholine receptor inducing activity (ARIA) and heregulin/Neu differentiation factor (NDF), respectively (for review).
1,2 These factors turned out to be products of alternative splicing of a single gene that yielded a variety of membrane-bound or secreted proteins. Collectively this group of proteins is referred to as neuregulin (NRG, now called NRG1). Since its discovery, NRG1 has been shown to be a mesenchymalderived factor that plays a critical role in the development of the heart and nervous system. The diverse activities of NRG1 are mediated by activation of the four members of the epidermal growth factor (EGF) family of receptor tyrosine kinases, designated EGFR, ErbB2, ErbB3 and ErbB4. NRG1 binds directly to ErbB3 and ErbB4, which can then act to induce ErbB2 and EGFR activity through heterodimerization of the receptors.
Analysis of mice containing targeted mutations in either ErbB2, ErbB4 or NRG1 provided the first hints that NRG1 might have siblings. [3] [4] [5] Mice lacking ErbB2, ErbB4 or NRG1 exhibit similar defects in the development of myocardial trabeculae in the ventricle and die during mid-embryogenisis (embryonic day (E) 10.5). These results suggest that NRG1, ErbB2 and ErbB4 are components of the same signaling pathway essential for the development of the heart. However, these studies also suggested that a novel ligand for ErbB4 may play a role in the development of the hind brain. NRG1 is expressed in the neuroepithelium and cells arising from rhombomeres 2, 4 and 6, while ErbB4 is expressed in rhombomeres 3 and 5. NRG1 and ErbB2 knockout mice exhibit a loss of cells and axons of the cranial sensory ganglia. In contrast, ErbB4 deficient mice do not exhibit this loss of cells. Rather, the Correspondence: Dr PJ Godowski, Department of Molecular Biology, Mailstop 37, Genentech Inc, 460 Pt San Bruno Blvd, South San Francisco, CA 94080, USA. E-mail:skiȰgene.com organization, spacing and pattern of innervation of these ganglia to and from the central nervous system is disrupted. One explanation for the striking difference in hindbrain phenotypes of NRG1 and ErbB4 knockout mice was that an additional ligand distinct from NRG1 might be recognized by ErbB4 in the CNS.
These prescient observations were supported by the recent discovery of two new genes that are structurally and functionally related to NRG1. Like NRG1, these genes are also ligands for members of the ErbB family of receptor tyrosine kinases and their expression pattern suggests they may have important functions in the nervous system. Four different laboratories have recently published articles characterizing a gene called NRG2, 6 ,7 Don-1 8 or NTAK.
9 NRG2/Don-1/NTAK (referred to here as NRG2) is not an alternatively spliced variant of NRG1. NRG2 is located on human chromosome 5q 8 while NRG1 is located on chromosome 8p11-22. 10, 11 Like NRG1, several alternatively spliced forms of NRG2 have been reported. The relative distribution and significance of these splice variants remain to be determined. NRG2 and NRG1 exhibit a similar domain structure: an Nterminal domain which resembles GGF, a C2-like Ig domain, an epidermal growth factor (EGF) domain which determines the receptor-binding specificity, a transmembrane domain and a large intracellular domain. The greatest region of homology between NRG2 and NRG1 is seen near the transmembrane domain (91%); significant homology is also observed in the Ig domain (36%), and the EGF domain (50%). While the intracellular domain (ICD) is only 24% homologous over the entire length, there are some small highly conserved regions (up to 89%) within that domain. 6 We recently identified a novel gene more distantly related to NRG1 and NRG2 named NRG3, which maps to human chromosome 10q22.
12 NRG3 has an EGF domain with 39% homology to that of NRG2 and 31% to NRG1. Like NRG2, the most highly conserved region of NRG3 with NRG1 lies in the extracellular domain very near the transmembrane domain (62%). This conservation suggests that this region may play an important role in molecular interactions. Unlike NRG1 and NRG2, NRG3 does not contain an Ig-like or kringle domain in its extracellular region. Instead, NRG3 has a Ser/Thr rich domain with a number of potential sites for O-linked glycosylation. Like its siblings, NRG3 also contains a large ICD but it is not well conserved with NRGs 1 and 2.
Initial studies of the properties of the NRG family members suggest they exhibit distinct biological roles. One indication stems from the analyses of the receptorbinding specificities and intracellular signaling pathways that occur following receptor binding. While NRG3 was shown to bind specifically to ErbB4, NRG1 and NRG2 bind to both ErbB3 and ErbB4. Interestingly, the overlapping receptor specificity of NRG1 and NRG2 does not seem to translate to similar responses of cells treated with these factors. NRG1 appears to be more potent than NRG2 in activating ErbB2 while the reverse is observed for activation of the EGFR. One explanation is that this may reflect a difference in the ability of these two ligands to promote heterodimerization of ErbB family members. 6 A second clue that the functions of the new neuregulins are different is that the expression of these ligands differs both spatially and temporally. [6] [7] [8] [9] 11 Both NRG1 and NRG2 mRNA are detected in the endothelial lining of the heart. NRG1 is more abundant in the ventricle than the atrium, while the converse is true for NRG2. In contrast, we did not detect NRG3 in the heart endo- cardium.
12 NRG1 is expressed in mesenchymal cells of various parenchymal organs, such as lung, intestine, stomach, kidney and the genital ridge. NRG2 and NRG3 are expressed at highest levels in the nervous system, although low levels of NRG2 are observed in the lung. 8 Within the CNS, the three ligands have different expression patterns. For example, expression of NRG1 in the developing cortex of E14.5 mice or postnatal day 0 rats corresponded mostly to the deeper layers (ventricular and subventricular zones) of the neuroepithelium which lines the lateral ventricles. In the E16 mouse (Figure 1, panel a) , NRG3 mRNA is enriched in the cortical plate. In the hippocampus of adult rats, no NRG1 expression can be detected, whereas NRG2 expression is limited to the dentate gyrus. In contrast, NRG3 is highly expressed in the hippocamal regions of CA1-CA3 pyramidal cells, as well as in granule cells in the dentate gyrus of adult mice (Figure 1, panel c) . The distribution of the three NRGs during neural development, combined with their unique receptor-binding properties, suggests that these gene products play distinct roles in vivo.
A comparison of the patterns of expression of NRG3 and ErbB4 in the telencephalon of E16 mice by in situ hybridization revealed that the ligand and the receptor are expressed in a complementary fashion. NRG3 expression is confined to the cortical plate (highly expressed in the subplate) of the telencephalon while ErbB4 is expressed in the subventricular and intermediate zones underlying the cortical plate (Figure 1 ). Cortical neuronal precursor cells are generated in the ventricular zones adjacent to the ventricle and migrate from this location to their final positions in the developing cortex. Thus, NRG3 seems to be expressed in more differentiated neurons. In the adult mouse, NRG3 is widely expressed in multiple layers of the cerebral cortex with escalated expression in the hippocampus (Figure 1c) . In contrast, ErbB4 is expressed in a punctate distribution in adult brain (Figure 1d ). The complementary pattern of NRG3 and ErbB4 is reminiscent of recent findings by C Rio et al, that cerebellar granule cells express NRG1 whereas radial glial cells express ErbB4, and that NRG1-ErbB interaction plays a crucial role in the migration of cerebellar granule cells along radial glial fibers. 13 Studies of the NRG3 expression in earlier stages are underway to determine if NRG3 is the 'missing ligand' for ErbB4 during cranial nerve formation. NRG2 may not be such a ligand due to its absence of expression in E9.5-E10 mouse embryos. 7 Identification of additional members of the NRG family affords new insight into the regulatory interactions of neuronal cells. Studies comparing NRG ligand and receptor expression patterns during various developmental stages, as well as studies of mice containing targeted mutations in these genes should help to elucidate the contributions of NRGs 1, 2 and 3. A diagram show-ing some of the known features of neuron-derived NRG1 is shown in Figure 2 . Stimulation of ErbB receptors may promote the production of other surface or secreted molecules from the recipient cells 14 and form a regulatory loop from glia to neurons. In addition, the large intracellular domains of most NRGs raise the interesting possibility that NRGs are themselves signaling molecules. These studies, along with the detailed characterization of the consequences of receptor activation by the 'new neuregulins' will keep neurobiologists busy for some time to come.
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